Neuroimmunology News

Jun 17, 2020
Evidence lacking for drug treatment of multiple sclerosis-related cognitive impairment
Systematic review of available drugs for treating multiple sclerosis fails to identify interventions effective for treating cognitive symptoms.
Jun 15, 2020
Case series: Teriflunomide therapy in COVID-19 patients with multiple sclerosis
Case series addresses concerns about whether immunotherapies for multiple sclerosis could influence risk for infection or lead to an unfavorable outcome.
Apr 16, 2020
Mental health and brain research must be a higher priority in global COVID-19 response
Paper highlights need to tackle harmful impacts of COVID-19 pandemic on mental health and potentially the brain and calls for more research on these areas.
Mar 27, 2020
FDA approves ozanimod for multiple sclerosis
Ozanimod is the latest in a series of novel medicines to originate from the laboratories of Scripps Research.
Mar 11, 2020
Diet has an impact on the multiple sclerosis disease course
Study shows the application of propionic acid in addition to multiple sclerosis medication reduces the relapse rate and the risk of disability progression in the long term.
Mar 10, 2020
Fatal overproduction of antibodies
Mutations in plasma cells play a key role in light chain amyloidosis.
Feb 27, 2020
Multi-sensor band quickly and simply records subtle changes in patients with multiple sclerosis
Patients with multiple sclerosis wear the small band on arms or legs, tap fingers or toes, and the resulting combined sensor data can be used to assess disease status and progression.
Feb 24, 2020
Ethnobotanical medicine is effective against the bacterium causing Lyme disease
A preclinical study in test tubes showed that selected plant-based herbal medicines, especially Ghanaian quinine and Japanese knotweed, work better than antibiotics.
Feb 05, 2020
Dietary interventions may slow onset of inflammatory and autoimmune disorders
Significantly reducing dietary levels of the amino acid methionine could slow onset and progression of inflammatory and autoimmune disorders.
Dec 27, 2019
NIH researchers discover new autoinflammatory disease and uncover its biological cause
Mutations in the RIPK1 gene responsible for CRIA syndrome.
Next ▶